Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer

Author:

Shimura MitsuhiroORCID,Mizuma Masamichi,Motoi FuyuhikoORCID,Kusaka Akiko,Aoki Shuichi,Iseki MasahiroORCID,Inoue Koetsu,Douchi DaisukeORCID,Nakayama Shun,Miura TakayukiORCID,Ishida Masaharu,Ohtsuka Hideo,Nakagawa KeiORCID,Morikawa TakanoriORCID,Kamei TakashiORCID,Unno Michiaki

Funder

Government of Japan Ministry of Education Culture Sports Science and Technology

Taiho Pharmaceutical

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference46 articles.

1. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

2. Japan pancreatic cancer registry; 30th year anniversary: Japan pancreas society;Egawa;Pancreas,2012

3. The results of pancreatic resections and long-term survival for pancreatic ductal adenocarcinoma: a single-institution experience;Seppänen;Scand J Surg : SJS : off organ Finnish Surg Soc Scandinavian Surg Soc,2017

4. Oncologic impact of local recurrence in resected pancreatic cancer and topographic preference in local recurrence patterns according to tumor location;Choi;Pancreas,2020

5. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head;Evans;J Clin Oncol,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3